Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case

Multi-kinase inhibitor sorafenib is the only one drug which increases life time in patients with advanced hepatocellular carcinoma (HCC). Results from the SHARP trial showed that median progression-free survival was less than 5 months. However, it is possible to achieve strong treatment effect for s...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Yu V Bisovskaya, V V Breder, B M Medvedeva, V A Gorbunova
Formáid: Artigo
Teanga:Russo
Foilsithe: IP Habib O.N. 2014-06-01
Sraith:Современная онкология
Ábhair:
hepatocellular carcinoma
sorafenib
chronic hepatitis b
lamivudine
Rochtain Ar Líne:https://modernonco.orscience.ru/1815-1434/article/view/26969
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla